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ABSTRACT 
CENTRAL OBESITY IN THE PRESENCE OF METABOLIC SYNDROME 
HAS ENHANCED OXIDATIVE STRESS 
Azlina AR, Taib R, Sayyedah N, Muid S, Osman M, Yusoff K, Ismail T, Nawawi H 
Faculty of Medicine, Universiti Teknologi MARA, Shah Alam 
Background: Metabolic syndrome (MS) is a cluster of abdominal obesity, 
atherogenic dyslipidaemia, hypertension and insulin resistance with or without 
hyperglycaemia associated with increased risk of coronary heart diseases. There may 
be a possible link between MS, central obesity and increased markers of oxidative 
stress. The oxidative stress in central obesity and MS with different glycaemic status 
is still unclear. 
Objective: The aim of our study was to evaluate the oxidative stress in central 
obesity and MS subjects with different glycaemic status and subjects with central 
obesity without MS. 
Design: A total of 260 subjects (Mean±SD : 53±11, 66 Males) were randomly 
recruited and divided into 5 groups: central obesity without MS (OBXMS), MS with 
diabetes (MSDM), MS with impaired fasting glucose (MSIFG), MS with 
normoglycaemia (MSNG) and normal control (NC). In addition, MSDM, MSIFG 
and MSNG were grouped as all MS group with a total number of 156. The blood 
levels of oxidized low-density lipoprotein (oxLDL) and 8-Isoprostane were 
evaluated. 
Results: OBXMS group was not significantly different compared to NC group. 
MSDM group compared to NC group had higher 8-Isoprostane (pO.OOl). MSIFG 
group compared to NC group had higher oxLDL (p<0.05) and 8-Isoprostane 
(pO.OOl). MSNG group compared to NC group had higher 8-Isoprostane (pO.OOl). 
All MS group compared to NC group had higher oxLDL (p<0.05) and 8-Isoprostane 
(pO.OOl). All MS group compared to OBXMS group had higher 8-Isoprostane 
(pO.OOl). 
Conclusions: MS irrespective of glycaemic status has enhanced oxidative stress 
compared to controls. There is enhanced oxidative stress in central obesity especially 
in the presence of MS, suggesting high coronary risk of MS subjects. 
Presented at Annual Scientific Meeting of Australian Atherosclerosis Society, 13-16 
October, 2009. 
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